$SYRS Syros Pharmaceuticals, Inc. Insider Trading Week 27/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Syros Pharmaceuticals, Inc. in week 27/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | C | 0.00 | 83,129 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Option Exercise | C | 0.00 | 4,366,825 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | P | 12.50 | 26,153 | 326,913 | 48,320 | 22.2 K to 48.3 K (+117.98 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | P | 12.50 | 373,847 | 4,673,088 | 1,538,333 | 1.2 M to 1.5 M (+32.10 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | C | 0.00 | 22,167 | 0 | 22,167 | 0 to 22.2 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Nashat Amir | Director | Buy | C | 0.00 | 1,164,486 | 0 | 1,164,486 | 0 to 1.2 M |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 83,129 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 4,366,825 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Buy | P | 12.50 | 26,153 | 326,913 | 48,320 | 22.2 K to 48.3 K (+117.98 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Buy | P | 12.50 | 373,847 | 4,673,088 | 1,538,333 | 1.2 M to 1.5 M (+32.10 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 22,167 | 0 | 22,167 | 0 to 22.2 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Polaris Management Co. VII, L. ... | 10% Owner | Buy | C | 0.00 | 1,164,486 | 0 | 1,164,486 | 0 to 1.2 M |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Option Exercise | C | 0.00 | 1,994,471 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Buy | C | 0.00 | 531,858 | 0 | 931,857 | 400 K to 931.9 K (+132.96 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Buy | C | 0.00 | 133,333 | 0 | 399,999 | 266.7 K to 400 K (+50.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Buy | C | 0.00 | 133,333 | 0 | 266,666 | 133.3 K to 266.7 K (+100.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | WuXi PharmTech Healthcare Fund ... | 10% Owner | Buy | C | 0.00 | 133,333 | 0 | 133,333 | 0 to 133.3 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 444,995 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,779,981 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 6,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 4,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 200,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | P | 12.50 | 80,000 | 1,000,000 | 918,664 | 838.7 K to 918.7 K (+9.54 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | P | 12.50 | 320,000 | 4,000,000 | 3,674,660 | 3.4 M to 3.7 M (+9.54 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 118,665 | 0 | 838,664 | 720 K to 838.7 K (+16.48 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 474,661 | 0 | 3,354,660 | 2.9 M to 3.4 M (+16.48 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 400,000 | 0 | 719,999 | 320 K to 720 K (+125.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,600,000 | 0 | 2,879,999 | 1.3 M to 2.9 M (+125.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 266,666 | 0 | 319,999 | 53.3 K to 320 K (+500.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 1,066,666 | 0 | 1,279,999 | 213.3 K to 1.3 M (+500.00 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 53,333 | 0 | 53,333 | 0 to 53.3 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Flagship Ventures Fund IV, L.P ... | 10% Owner | Buy | C | 0.00 | 213,333 | 0 | 213,333 | 0 to 213.3 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 151,576 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 117,931 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 982,762 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 178,074 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 317,853 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | P | 12.50 | 9,373 | 117,163 | 49,793 | 40.4 K to 49.8 K (+23.19 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | P | 12.50 | 174,320 | 2,179,000 | 205,767 | 31.4 K to 205.8 K (+554.33 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | P | 12.50 | 104,670 | 1,308,375 | 366,739 | 262.1 K to 366.7 K (+39.94 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | P | 12.50 | 144,383 | 1,804,788 | 191,869 | 47.5 K to 191.9 K (+304.05 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 40,420 | 0 | 40,420 | 0 to 40.4 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 31,447 | 0 | 31,447 | 0 to 31.4 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 262,069 | 0 | 262,069 | 0 to 262.1 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 47,486 | 0 | 47,486 | 0 to 47.5 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 84,760 | 0 | 84,760 | 0 to 84.8 K |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | P | 12.50 | 400,000 | 5,000,000 | 4,637,137 | 4.2 M to 4.6 M (+9.44 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 423,805 | 0 | 4,237,137 | 3.8 M to 4.2 M (+11.11 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 2,000,000 | 0 | 3,813,332 | 1.8 M to 3.8 M (+110.29 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 1,333,333 | 0 | 1,813,332 | 480 K to 1.8 M (+277.78 %) |
| Jul 07 2016 | SYRS | Syros Pharmaceutic ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 266,666 | 0 | 479,999 | 213.3 K to 480 K (+125.00 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | WuXi Healthcare Ventures II, L ... | 10% Owner | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | WuXi Healthcare Ventures II, L ... | 10% Owner | Buy | C | 0.00 | 423,805 | 0 | 423,805 | 0 to 423.8 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Bancel Stephane | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Bancel Stephane | Director | Buy | C | 0.00 | 26,666 | 0 | 47,980 | 21.3 K to 48 K (+125.11 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | C | 0.00 | 150,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | C | 0.00 | 150,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | C | 0.00 | 150,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Option Exercise | C | 0.00 | 550,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Buy | C | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Buy | C | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Buy | C | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | SHARP PHILIP A | Director | Buy | C | 0.00 | 146,666 | 0 | 146,666 | 0 to 146.7 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President and CEO | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President and CEO | Buy | C | 0.00 | 66,666 | 0 | 370,702 | 304 K to 370.7 K (+21.93 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,589,269 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | P | 12.50 | 400,000 | 5,000,000 | 4,637,137 | 4.2 M to 4.6 M (+9.44 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 423,805 | 0 | 4,237,137 | 3.8 M to 4.2 M (+11.11 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 2,000,000 | 0 | 3,813,332 | 1.8 M to 3.8 M (+110.29 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 1,333,333 | 0 | 1,813,332 | 480 K to 1.8 M (+277.78 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 266,666 | 0 | 479,999 | 213.3 K to 480 K (+125.00 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Option Exercise | C | 0.00 | 1,907,122 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 12.50 | 400,000 | 5,000,000 | 908,565 | 508.6 K to 908.6 K (+78.65 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | C | 0.00 | 508,565 | 0 | 508,565 | 0 to 508.6 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 508,566 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 508,566 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,186,654 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 1,186,654 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 12.50 | 120,000 | 1,500,000 | 628,566 | 508.6 K to 628.6 K (+23.60 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 12.50 | 120,000 | 1,500,000 | 628,566 | 508.6 K to 628.6 K (+23.60 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 12.50 | 280,000 | 3,500,000 | 1,466,654 | 1.2 M to 1.5 M (+23.60 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 12.50 | 280,000 | 3,500,000 | 1,466,654 | 1.2 M to 1.5 M (+23.60 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 508,566 | 0 | 508,566 | 0 to 508.6 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 508,566 | 0 | 508,566 | 0 to 508.6 K |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,186,654 | 0 | 1,186,654 | 0 to 1.2 M |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,186,654 | 0 | 1,186,654 | 0 to 1.2 M |